For decades, patients and caregivers have experienced firsthand that only a select few ALS patients have access to the best clinics, testing and treatment options. We were told not to waste our time trying to understand our particular version of ALS but instead accept a care system and generic therapies that did nothing to change the outcome of the disease.
Like cancer before, a better way is now possible for all ALS patients. Thanks to advances in science, technology and computational analytics we are beginning to be able to identify and treat each patient’s unique disease. Synapticure was built by leading patient and caregiver advocates alongside leading ALS clinicians, biotech executives and telemedicine executives to bring the ALS care and treatment experience into the 21st century.
Location: United States, Illinois, Chicago
Employees: 11-50
Total raised: $6M
Founded date: 2019
Investors 4
| Date | Name | Website |
| 01.02.2022 | Y Combinat... | ycombinato... |
| 02.07.2023 | Optum Vent... | optumventu... |
| 24.02.2022 | Lifeforce ... | lifeforcec... |
| 03.02.2022 | GV | gv.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 02.02.2022 | Seed | $6M | - |
Mentions in press and media 3
| Date | Title | Description |
| 15.04.2024 | Synapticure and the ALS Association Partner to Expand Telehealth Access for People Living with ALS Nationwide | Telemedicine for ALS Partnership Aims to Bridge the Gap in Care Delivery CHICAGO, April 15, 2024 /PRNewswire/ -- Synapticure, a leading telemedicine company focused on improving the lives of people and caregivers living with neurodegenerati... |
| 26.11.2023 | Fighting the good fight against ALS | The first time "Sunday Morning" met Brian Wallach, in 2021, we feared it might be our last. He was already four years into a diagnosis of amyotrophic lateral sclerosis (or ALS), a rare and incurable disease that on average takes p... |
| 02.02.2022 | Synapticure Raises $6M in Seed Funding | Synapticure, a Chicago, IL-based teleneurology company providing personalized care for people living with ALS (Amyotrophic Lateral Sclerosis) and their families, launched with $6m in seed funding. The round was led by GV (formerly Google Ve... |